Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 12, 2018 11:16 ET | Source: Myriad Genetics, Inc.

Myriad Receives FDA Approval of BRACAnalysis CDx® as Companion Diagnostic for Lynparza™ (olaparib) In Patients with Metastatic Breast Cancer

SALT LAKE CITY, Jan. 12, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that the U.S. Food and Drug...
January 12, 2018 10:53 ET | Source: SparingVision

SparingVision Participated in the 10th Annual Biotech Showcase

PARIS, Jan. 12, 2018 (GLOBE NEWSWIRE) -- SparingVision, a biotechnology company focused on the discovery and development of an innovative, therapeutic approach for treatment of blinding inherited...
January 12, 2018 10:11 ET | Source: American Society of Plastic Surgeons

Plastic Surgeons at High Risk for Work-Related Musculoskeletal Injuries

Arlington Heights, Jan. 12, 2018 (GLOBE NEWSWIRE) -- Plastic Surgeons at High Risk for Work-Related Musculoskeletal Injuries Plastic surgeons are more susceptible to developing painful...
January 12, 2018 09:30 ET | Source: The Steadman Clinic

The Steadman Clinic, SPRI and Smith & Nephew Host Annual Vail Hip Symposium

Vail, Colorado, Jan. 12, 2018 (GLOBE NEWSWIRE) -- The Steadman Clinic (TSC) and the Steadman Philippon Research Institute, (SPRI) have joined with host Smith & Nephew to present the 2018 Vail...
January 12, 2018 08:00 ET | Source: OPKO Health, Inc.

OPKO’S GeneDx Announces Research Collaboration with Radboud University Medical Center

MIAMI, Jan. 12, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK), announces today that GeneDx, Inc., a subsidiary of OPKO’s BioReference Laboratories, has entered into a research...
January 12, 2018 07:00 ET | Source: Pluristem Therapeutics, Inc.

Pluristem’s PLX Cells Significantly Inhibit Cancer Cell Growth in Newly Published Study

PLX cells exhibit anti-proliferative effect on a wide range of human cancer cell typesPre-clinical study results show statistically significant reduction in tumor size as well as complete tumor...
January 11, 2018 16:53 ET | Source: Aradigm Corporation

Aradigm Reports Results of FDA Advisory Committee Meeting on Linhaliq

HAYWARD, Calif., Jan. 11, 2018 (GLOBE NEWSWIRE) -- Aradigm Corporation (NASDAQ:ARDM) (the “Company”) today announces that the Antimicrobial Drugs Advisory Committee (ADAC) of the US Food and Drug...
January 11, 2018 14:39 ET | Source: Aldelano

Hurricane Devastated Areas Receiving First Solar Relief from Tennessee Production Facility

Jackson, Tennessee, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Pulling moisture from the air and energy from the sun, 16,000 servings of water per day are produced from a solar product, simply called, the...
January 11, 2018 13:39 ET | Source: OTraces, Inc.

OTraces’ TME Cancer Blood Test Presentation at Innovation Challenge Spurs Investor Interest from JP Morgan Healthcare Conference Participants

SAN FRANCISCO and BALTIMORE, Jan. 11, 2018 (GLOBE NEWSWIRE) -- OTraces Inc., a Sykesville, Maryland-based cancer diagnostics company with a unique patented and patent-pending blood test which...
January 11, 2018 12:05 ET | Source: Alzheimer's Foundation of America

Alzheimer’s Foundation of America Announces 2018 National “Educating America” Tour

NEW YORK, Jan. 11, 2018 (GLOBE NEWSWIRE) -- The Alzheimer’s Foundation of America (AFA) today announced its 2018 “Educating America” Tour, which brings Alzheimer’s-related educational conferences to...